Key points from article :
TAME trial an attempt to determine whether it can directly address aging.
The only way to fund a clinical trial out of it is philanthropic.
Trial can immediately focus on efficacy, no stringent tests of safety like in new drugs.
The money can power the study well enough to achieve statistically significant results.
Description of trial incorporates a de facto definition of aging as the clinical endpoint.
That is roughly FDA-approved and can be used in future aging intervention trials.
There is a reasonable chance that the trial will succeed.
